Veracyte | VCYT - Des Atouts





Des Atouts Changement Date
Agenus USD 186.46M 40.34M 2026-03
Agilent USD 13.07B 252M 2026-03
Anika Therapeutics USD 183.47M 4.09M 2026-06
Arrowhead Research USD 2.11B 156.25M 2026-06
Bruker USD 6.05B 77.8M 2026-06
Heron Therapeutics USD 246.22M 9.66M 2026-03
Illumina USD 6.65B 91M 2026-06
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Laboratory Of America USD 18.53B 554.8M 2026-06
Ligand Pharmaceuticals USD 1.53B 28.53M 2026-03
Myriad Genetics USD 638.9M 34.8M 2026-06
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Siemens EUR 167.97B 2.16B 2026-03
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Veracyte USD 1.49B 49.97M 2026-06
Waters USD 24.75B 220M 2026-06